Arbutus Biopharma Corporation - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Brookfield completes $3bn Oaktree buyout as credit platform reaches $365 bn

Williams to buy Momentum Midstream for $5.5bn as Haynesville LNG strategy accelerates

Snap revenue jumps 19% as AI advertising tools revive $SNAP investor confidence

Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test

Moderna Inc. resolves global mRNA patent battle in $2.25 billion deal, removing major legal risk

Read More

Pharma Industry News

What Moderna Inc.’s settlement with Arbutus Biopharma Corporation means for the future of mRNA medicines

Moderna stock surged after hours after settling a $2.25B patent dispute with Arbutus Biopharma and Genevant Sciences. Discover what it means for mRNA vaccines.

byPallavi Madhiraju

March 4, 2026

web analytics